Table 3 Association of the N363S (p = 0.878), BCLI (p = 0.343), ER2223EK (p = 0.966) and disease severity.
GOLD | Wild-type | Heterozygote | Homozygote | |
|---|---|---|---|---|
N363S Polymorphism- n (%) | ||||
Chronic bronchitis | 23 | 21 (91.3) | 2 (8.7) | 0 (0.0) |
GOLD I | 8 7 | (87.5) | 1 (12.5) | 0 (0.0) |
GOLD II | 66 | 58 (87.9) | 8 (12.1) | 0 (0.0) |
GOLD III | 50 | 45 (90.0) | 5 (10.0) | 0 (0.0) |
GOLD IV | 60 | 54 (90.0) | 6 (10.0) | 0 (0.0) |
BCLI Polymorphism- n (%) | ||||
chronic bronchitis | 23 | 9 (39.1) | 11 (47.8) | 3 (13.0) |
GOLD I | 8 | 1 (12.5) | 5 (62.5) | 2 (25.1) |
GOLD II | 66 | 24 (36.4) | 31 (47.0) | 11 (16.7) |
GOLD III | 50 | 21 (42.0) | 20 (40.0) | 9 (18.0) |
GOLD IV | 60 | 28 (46.7) | 25 (41.7) | 7 (11.7) |
ER2223EK Polymorphism- n (%) | ||||
chronic bronchitis | 23 | 23 (100) | 0 (0.0) | 0 (0.0) |
GOLD I | 8 | 7 (87.5) | 1 (12.5) | 0 (0.0) |
GOLD II | 66 | 63 (95.5) | 3 (4.6) | 0 (0.0) |
GOLD III | 50 | 47 (94.0) | 3 (6.0) | 0 (0.0) |
GOLD IV | 60 | 58 (96.7) | 2 (3.3) | 0 (0.0) |